Yahoo! Finance Search - Finance Home - Yahoo! - Help

Saturday, October 10 2015 3:05am ET - U.S. Markets Closed.
Industry Center - Drugs - Generic
Industry Center > Drugs - Generic > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Drugs - Generic News
Latest News
Friday, Oct 9, 2015
·Parnell to Report Financial Results for the Nine Months Ended September 30, 2015 on October 21, 2015
GlobeNewswire - Fri 1:00 pm ET
·Parnell Pharmaceuticals Holdings Ltd Restructures Board
GlobeNewswire - Fri 11:00 am ET
·Amgen Was Clobbered in September -- Here's Why
at Motley Fool - Fri 8:23 am ET
·Horizon passes regulatory hurdle in pursuit of Depomed
AP - Fri 8:09 am ET
·FDA Accepts Supplemental New Drug Application (sNDA) for DALVANCE┬« (dalbavancin)
PR Newswire - Fri 7:01 am ET
Thursday, Oct 8, 2015
·Mylan to Host Investor Conference Call and Webcast for Perrigo Shareholders
PR Newswire - Thu 4:44 pm ET
·Allergan To Host R&D Day And Third Quarter 2015 Conference Call And Webcast November 4
PR Newswire - Thu 4:15 pm ET
·NBIX: Positive Results for Kinect-3; NDA for NBI-98854 in 2016; increasing PT to $70
- Thu 3:20 pm ET
·Neurocrine Biosciences (NBIX) Stock Spikes on Positive Phase 3 Results
at - Thu 12:09 pm ET
·Neurocrine Tardive Dyskinesia Drug Hits, Stock Jumps
at Investor's Business Daily, Inc. - Thu 11:33 am ET
·Neurocrine Biosciences Rises as Drug Fights Movement Disorder
at Bloomberg - Thu 10:57 am ET
·Hot Political Rhetoric Hammers Specialty Pharmaceuticals: 3 to Buy Now
- Thu 10:15 am ET
·Big pharma thinks twice about jacking up drug prices
at - Thu 10:11 am ET
·Prescription Scar Gel Leads Oculus' Charge in Dermatology
- Thu 9:27 am ET
·Neurocrine Bio Soars on Positive Phase 3 Results
- Thu 9:10 am ET
·Fibrocell and Intrexon Announce Poster Presentation on FCX-007 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB) at American Society of Human Genetics Annual Meeting
GlobeNewswire - Thu 8:05 am ET
·Allergan Anti-Infective Portfolio Highlighted in 13 Abstracts at IDWeek 2015
PR Newswire - Thu 7:01 am ET
·Clinical Data on Mallinckrodt Pharmaceuticals' H.P. Acthar┬« Gel to be Unveiled at American College of Rheumatology
PR Newswire - Thu 6:45 am ET
·Neurocrine Announces Positive Results from Phase III Kinect 3 Study of NBI-98854 in Tardive Dyskinesia
PR Newswire - Thu 6:30 am ET
Wednesday, Oct 7, 2015
·Zynerba Pharmaceuticals to Present at BIO Investor Forum 2015
GlobeNewswire - Wed Oct 7
More Latest News...

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drugs - Generic Headlines
More Finance RSS Feeds

Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2015 Morningstar, Inc. All Rights Reserved. Company information © 2015 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2015, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?